INDEX PHARMACEUTICALS

index-pharmaceuticals-logo

InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.

#SimilarOrganizations #People #Financial #Event #Website #More

INDEX PHARMACEUTICALS

Social Links:

Industry:
Biopharma Biotechnology Medical

Founded:
2000-01-01

Address:
Stockholm, Stockholms Lan, Sweden

Country:
Sweden

Website Url:
http://www.indexpharma.com

Total Employee:
11+

Status:
Active

Contact:
46 8 50 88 47 30

Email Addresses:
[email protected]

Total Funding:
31.85 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

yilmaz-mahshid_image

Yilmaz Mahshid Board Member @ InDex Pharmaceuticals
Board_member
2020-04-01

wenche-rolfsen_image

Wenche Rolfsen Chairwoman of the Board of Directors @ InDex Pharmaceuticals
Board_member
2016-01-01

hansson-lennart_image

Hansson Lennart Board of directors @ InDex Pharmaceuticals
Board_member

erik-amble_image

Erik Amble Board of directors @ InDex Pharmaceuticals
Board_member

viktor-drvota_image

Viktor Drvota Board of directors @ InDex Pharmaceuticals
Board_member

wenche-rolfsen_image

Wenche Rolfsen Chairman of the Board @ InDex Pharmaceuticals
Board_member
2011-02-01

Current Employees Featured

not_available_image

Christine Dieterich Johansson
Christine Dieterich Johansson Senior Project Manager CMC and Pre-clinical @ InDex Pharmaceuticals
Senior Project Manager CMC and Pre-clinical

johan-gileus_image

Johan Gileus
Johan Gileus Chief Financial Officer @ InDex Pharmaceuticals
Chief Financial Officer

thomas-knittel_image

Thomas Knittel
Thomas Knittel Chief Medical Officer @ InDex Pharmaceuticals
Chief Medical Officer
2012-01-01

per-olof-gunnesson_image

Per-Olof Gunnesson
Per-Olof Gunnesson VP Finance&Business Development @ InDex Pharmaceuticals
VP Finance&Business Development
2002-06-01

peter-zerhouni_image

Peter Zerhouni
Peter Zerhouni Chief Executive Officer @ InDex Pharmaceuticals
Chief Executive Officer

Founder


not_available_image

Svante Rasmuson

Investors List

vinnova_image

Vinnova

Vinnova investment in Grant - InDex Pharmaceuticals

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - InDex Pharmaceuticals

vinnova_image

Vinnova

Vinnova investment in Grant - InDex Pharmaceuticals

industrifonden_image

Industrifonden

Industrifonden investment in Venture Round - InDex Pharmaceuticals

neomed-management_image

Neomed Management

Neomed Management investment in Venture Round - InDex Pharmaceuticals

seb-venture-capital_image

SEB Venture Capital

SEB Venture Capital investment in Venture Round - InDex Pharmaceuticals

seb-venture-capital_image

SEB Venture Capital

SEB Venture Capital investment in Private Equity Round - InDex Pharmaceuticals

industrifonden_image

Industrifonden

Industrifonden investment in Private Equity Round - InDex Pharmaceuticals

Official Site Inspections

http://www.indexpharma.com Semrush global rank: 6.08 M Semrush visits lastest month: 1.34 K

  • Host name: 104.21.27.139
  • IP address: 104.21.27.139
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "InDex Pharmaceuticals"

InDex Pharmaceuticals strengthens the organization with Eva

May 2, 2022 โ€“ InDex Pharmaceuticals Holding AB (publ) today announced that the company has appointed Eva Arlander as Chief Development Officer. Eva will also be part of the โ€ฆSee details»

InDex Pharmaceuticals AB - LinkedIn

Indexpharma.com 59 Like Comment Share InDex Pharmaceuticals AB 1,474 followers 7mo Report this post Today, InDex Pharmaceuticals Holding AB published the Annual Report for โ€ฆSee details»

InDex Pharmaceuticals provides a company update โ€“ Flerie

Apr 8, 2024 E-mail: [email protected]. Johan Giléus, CFO and deputy CEO Phone: +46 8 122 038 50 E-mail: [email protected]. Publication The โ€ฆSee details»

About Us โ€“ Index Pharmaceuticals

Founded in 1998 by the forward-thinking Mr. Amish Shah, Index Pharma LLP emerged from his seven-year immersion in the pharmaceutical industry, where he cultivated relationships and established a lasting legacy.See details»

InDex Pharmaceuticals - PitchBook

Information on acquisition, funding, cap tables, investors, and executives for InDex Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report โ€ฆ

Request to [email protected], or by mail to InDex Pharmaceuticals Holding AB (publ), Berzelius väg 13, 171 65 Solna, Sweden. For more information: Jenny Sundqvist, CEO โ€ฆSee details»

Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ ...

The Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to [email protected],or by mail to InDex Pharmaceuticals Holding AB โ€ฆSee details»

InDex Pharmaceuticals - Craft

Aug 13, 2024 InDex Pharmaceuticals has 5 employees at their 1 location and kr97.51 m in annual revenue in FY 2023. See insights on InDex Pharmaceuticals including office locations, โ€ฆSee details»

InDex Pharmaceuticals strengthens the clinical development โ€ฆ

Aug 23, 2021 E-mail: [email protected]. Publication The information was submitted for publication through the agency of the contact person set out above at 08:00 CET โ€ฆSee details»

Press releases โ€“ InDex Pharmaceuticals

InDex Pharmaceuticals Holding AB (publ) is the parent company of the Group, which also includes InDex Pharmaceuticals AB and InDex Pharmaceuticals ABโ€™s wholly owned subsidiary โ€ฆSee details»

InDex Pharmaceuticals strengthens the organization with Eva โ€ฆ

May 2, 2022 InDex is based in Stockholm, Sweden. The companyโ€™s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm. Redeye AB with email address โ€ฆSee details»

InDex Pharmaceuticals Holding AB (publ) interim report January ...

Nov 23, 2022 The Board has appointed Jenny Sundqvist as new CEOSee details»

Index Pharmaceuticals: InDex Pharmaceuticals enters agreement โ€ฆ

Mar 30, 2021 E-mail: [email protected]. Publication The information was submitted for publication through the agency of the contact person set out above at 8:00 CET โ€ฆSee details»

InDex Pharmaceuticals provides an update on companyโ€™s future

Feb 26, 2024 E-mail: [email protected]. Johan Giléus, CFO and deputy CEO Phone: +46 8 122 038 50 E-mail: [email protected]. Publication The โ€ฆSee details»

InDex Pharmaceuticals enters agreement with Parexel Biotech for โ€ฆ

STOCKHOLM, March 30, 2021 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company has entered an agreement for services with global clinical โ€ฆSee details»

InDex Pharmaceuticals enters agreement with Parexel Biotech for โ€ฆ

Mar 30, 2021 E-mail: [email protected] Publication The information was submitted for publication through the agency of the contact person set out above at 8:00 CET โ€ฆSee details»

Index Pharmaceuticals

Index Pharma has facilitated more than 15 audits for our customers and suppliers. Our 3rd party audits foster trust, support customers and suppliers, facilitating seamless business in India.See details»

InDex Pharmaceuticals Holding AB (publ) publishes Annual ... - Flerie

Apr 8, 2022 The Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to [email protected], or by mail to InDex โ€ฆSee details»

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report โ€ฆ

Apr 23, 2021 The printed Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to [email protected], or by mail to InDex โ€ฆSee details»

linkstock.net © 2022. All rights reserved